RT Book, Section
A1 Hung, Jui-Sung
A1 Lau, Kean-Wah
A1 Yeung, Alan C.
A2 Samady, Habib
A2 Fearon, William F.
A2 Yeung, Alan C.
A2 King III, Spencer B.
SR Print(0)
ID 1146603303
T1 Inoue-Balloon Mitral Valvuloplasty
T2 Interventional Cardiology, 2e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071820363
LK accesscardiology.mhmedical.com/content.aspx?aid=1146603303
RD 2024/04/24
AB The  introduction  of  percutaneous  balloon  mitral  valvuloplasty  (BMV)  by  Inoue  et  al1  in  1982  has  opened  a  new  dimension  in  the  treatment  of  patients  with  mitral  stenosis.  The  body  of  data  accrued  to  date  has  clearly  established  this  invasive,  nonsurgical  procedure  as  the  treatment  of  choice  in  symptomatic  patients  with  moderate  to  severe  mitral  stenosis  (mitral  valve  area  <1.5  cm2)  and  favorable  valve  morphology  (noncalcified,  pliable  valve  with  minimal  subvalvular  disease  and  no  or  mild  mitral  regurgitation).2-5  The  presence  of  either  severe  (grade  ≥3)  angiographic  mitral  regurgitation  or  left  atrial  thrombus  is  considered  to  be  a  contraindication  for  BMV.  However,  several  controversial  issues  in  the  use  of  this  procedure  exist,  because  the  selection  of  patients  for  BMV  in  clinical  practice  continues  to  be  a  complex  decision  involving  consideration  of  multiple  variables,  including  clinical  profile,  operator  skill,  valve  morphology,  and  severity  of  associated  mitral  regurgitation.